Coya Therapeutics’ COYA 301 Increased Treg Function and Halted Cognitive Decline in an Open Label Study in Patients with Alzheimer’s Disease - Allele Capital

https://ir.coyatherapeutics.com/news/news-details/2023/Coya-Therapeutics-COYA-301-Increased-Treg-Function-and-Halted-Cognitive-Decline-in-an-Open-Label-Study-in-Patients-with-Alzheimers-Disease/default.aspx